Managing Diabetes in Long-Term Care Facilities: Benefits of Switching From Human Insulin to Insulin Analogs
To access this article, please choose from the options below
Financial support for preparation of this manuscript was provided by Novo Nordisk.
PII: S1525-8610(09)00199-6
doi:10.1016/j.jamda.2009.05.009
© 2010 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.
